Apogee Biotechnology
Business Services · Pennsylvania, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1214 W End Ave Ste 2015, Hummelstown, Pe...Phone Number
(717) 531-4758Website
www.apogee-biotech.comRevenue
<$5 MillionIndustry
About Apogee Biotechnology
Apogee Biotechnology Corporation, founded in 2001 and based in Hershey, Pennsylvania, focuses on developing orally available small molecules for cancer and inflammatory disease treatments. The company is dedicated to advancing its sphingosine kinase inhibitor program, particularly targeting solid tumors and chronic inflammatory diseases. Their product pipeline includes the clinical lead compound ABC294640 (opaganib), which has shown efficacy in various cancers and inflammatory conditions, as well as in COVID-19 patients. Apogee is privately held and primarily funded through grants, including those from the NIH and the Pennsylvania Department of Health.Explore more
SIC Code 87,873NAICS Code 54,541Show moreApogee Biotechnology Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Apogee Biotechnology
Compare insights from companies similar to Apogee Biotechnology, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Apogee Biotechnology Tech Stack
A closer look at the technologies used by Apogee Biotechnology
See more technologies
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Apogee Biotechnology
Sign Up For FreeTo access detailed company insights
Apogee Biotechnology Corporation, founded in 2001 and based in Hershey, Pennsylvania, focuses on developing orally available small molecules for cancer and inflammatory disease treatments. The company is dedicated to advancing its sphingosine kinase inhibitor program, particularly targeting solid tumors and chronic inflammatory diseases. Their prod... Read More
